Novavax to seek US authorization of its coronavirus vaccine by the end of the year
Written by Black Hot Fire Network on November 6, 2021
"We'll have a file in the US hopefully before the end of the year," Erck said.
If the FDA gives the green light, the first 100 million doses of the protein-based vaccine will be ready to ship following authorization, Erck said.